|
29 Apr 2020 |
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
|
|
27 Apr 2020 |
Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies
|
|
27 Apr 2020 |
Merck and Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers
|
|
24 Apr 2020 |
ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)
|
|
23 Apr 2020 |
EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations
|
|
22 Apr 2020 |
Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138
|
|
22 Apr 2020 |
Targovax and Valo Therapeutics Enter Collaboration to Develop RAS Neoantigen Coating of ONCOS Viruses Using PeptiCRAd Technology
|
|
21 Apr 2020 |
Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-Derived Regulatory T Cells
|
|
21 Apr 2020 |
Esperion Announces Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of NEXLETOL™ (bempedoic acid) and NEXLIZET™ (bempedoic acid and ezetimibe) Tablets in Japan
|
|
20 Apr 2020 |
COVID-19: 155 drugs and 79 vaccines under development worldwide
|
|
17 Apr 2020 |
Kubota Vision Announces Signing of Open Innovation Agreement with LEO Pharma A/S to Screen Novel VAP-1 Inhibitor Compounds for Inflammatory Skin Diseases
|
|
17 Apr 2020 |
LegoChem Biosciences and Iksuda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
|
|
16 Apr 2020 |
Galapagos and Ryvu Announce Research Collaboration
|
|
15 Apr 2020 |
Y-mAbs enters into Worldwide Exclusive License Agreement for SADA Technology – a Novel Radioimmunotherapy Platform
|
|
15 Apr 2020 |
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
|
|
15 Apr 2020 |
TScan Announces Collaboration with Novartis on the Discovery and Development of Novel T Cell Receptor Therapies for the Treatment of Solid Tumors
|
|
14 Apr 2020 |
MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401
|
|
08 Apr 2020 |
Global COVID-19 Clinical Trial Tracker launched by Cytel
|
|
08 Apr 2020 |
Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform
|
|
07 Apr 2020 |
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline
|
|
06 Apr 2020 |
Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery
|
|
04 Apr 2020 |
Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline
|
|
04 Apr 2020 |
panCELLa Extends Exclusive License to Astellas
|
|
02 Apr 2020 |
Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma
|
|
02 Apr 2020 |
Horizon Therapeutics plc Acquires Curzion Pharmaceuticals, Inc. and Its LPAR1 Antagonist Product Candidate to Expand Development-Stage Pipeline
|
